Tesamorelin is a synthetic 44-amino-acid analog of growth hormone-releasing hormone (GHRH) with an N-terminal trans-3-hexenoyl modification for enhanced stability. It is widely researched for its potent and selective stimulation of pulsatile growth hormone release from the anterior pituitary, leading to increased IGF-1 levels. Preclinical and research models utilize it to investigate lipolytic effects, visceral fat reduction, lipid metabolism, and muscle anabolism.
• Purity: ≥99% (HPLC verified)
• Sequence: trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH₂
• CAS No.: 218949-48-5
• Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
• Molecular Weight: 5135.9 g/mol
• Form: Lyophilized powder
• Solubility: Reconstitute with bacteriostatic water or sterile saline
• Storage: Freeze-dried at -20°C; reconstituted at 2–8°C for up to 30 days
• Includes: Third-party Certificate of Analysis (COA) with every order
Disclaimer: This product is sold strictly for laboratory and in-vitro research purposes only. It is not intended for human or animal consumption, medical, diagnostic, therapeutic, or veterinary use. Not evaluated by Health Canada or the FDA. The purchaser is solely responsible for ensuring compliance with all applicable laws and regulations in Quebec, Canada.
